K. S. Baker

TL;DR: Although prevalence of conception is diminished after HCT, if pregnancy does occur, outcome is likely to be favorable and patients should be counseled prior to transplant regarding strategies to preserve fertility.

TL;DR: It is concluded that metabolic syndrome occurs frequently among allogeneic HCT survivors who are seen by transplant physicians, and approaches to screening, prevention and management of metabolic syndrome should be developed for HCT recipients.

TL;DR: Outcomes after unrelated donor hematopoietic cell transplantation for 91 patients with hemophagocytic lymphohistiocytosis transplanted in the US in 1989–2005 demonstrate that a BU/CY/VP16-conditioning regimen provides cure in approximately 50% of patients and future studies should explore strategies to lower early mortality.

TL;DR: Although numbers are limited, HCT appears to be effective therapy for correcting and preventing hematologic and immunologic complications of CHS, and an unrelated donor may be a suitable alternative for patients without an HLA-matched sibling.

TL;DR: Spontaneously produced and LPS-stimulated IL-10 levels were correlated with the development of transplant-related complications (TRC) including grade II–IV acute GVHD, veno-occlusive disease, idiopathic pneumonia syndrome and multi-organ dysfunction syndrome, and with death before day 100.